Screener/Healthcare/Biotechnology

PHAT

Phathom Pharmaceuticals, Inc.NASDAQ
$10.52+0.46 (+4.52%)
$2.21
$18.31
$10.21
$10.61
EPS (TTM)$-3.04
P/E Ratio
Dividend Yield
Market Cap$877.4M
Volume88K
Prev Close$10.06
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$57.6M-$21.1M$-0.2786.7%-36.7%
Q3 '25$49.5M-$30.0M$-0.4187.5%-60.5%
Q2 '25$39.5M-$75.8M$-1.0587.2%-191.9%
Q1 '25$28.5M-$94.3M$-1.3186.9%-330.7%
Q4 '24$29.7M-$74.5M$-1.0087.1%-251.0%
Q3 '24$16.4M-$85.6M$-1.3285.6%-523.3%
Q2 '24$7.3M-$91.4M$-1.5681.2%-1248.6%
Q1 '24$1.9M-$82.9M$-1.4277.7%-4333.3%
Get Your Daily Market Recap